Fulgent Genetics (FLGT) Capital Expenditures Growth (3y) (2018 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) Capital Expenditures Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 93.09% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 9.89% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 8.41% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 25.00% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -4.38% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -31.58% |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -31.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.77% |
| Mar 31, 2026 | 36.75% |
| Dec 31, 2025 | 1.79% |
| Sep 30, 2025 | 3.64% |
| Jun 30, 2025 | 27.96% |
| Mar 31, 2025 | -4.16% |
| Dec 31, 2024 | -14.21% |
| Sep 30, 2024 | 79.08% |
| Jun 30, 2024 | 63.99% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | -49.27% |
| Sep 30, 2023 | -21.38% |
| Jun 30, 2023 | 209.15% |
| Mar 31, 2023 | 36.71% |
| Dec 31, 2022 | 117.17% |
| Sep 30, 2022 | 295.28% |
| Jun 30, 2022 | 86.90% |
| Mar 31, 2022 | 242.00% |
| Dec 31, 2021 | 265.04% |
| Sep 30, 2021 | 48.11% |